Nu Skin appears caught in a structural demand contraction, with revenue falling 17.1% year over year to $320.1M in 2026Q2 — the tenth consecutive quarter of decline — while gross margin of 68.2% trails the 71.3%–78.3% peer range, suggesting cost cuts of roughly 31% off the 2024Q4 SG&A base have masked rather than…
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 5, 2026 | $0.10-52.4% vs $0.21 | $311M-5.4% vs $329M |
Q3 2026 Aug 10, 2026 | $0.20+0.0% vs $0.20 | $320M-7.3% vs $345M |
Q2 2026 May 7, 2026 | $0.14-6.7% vs $0.15 | $321M-2.8% vs $330M |
Q1 2026 Feb 12, 2026 | $0.29-3.3% vs $0.30 | $370M-3.2% vs $383M |
Nu Skin Enterprises, Inc. ( NUS ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants B.G. Hunt - VP of Treasurer, Investor Relations & Admin Services Ryan Napierski - President, CEO & Director Chelsea Lantz - Chief Financial Officer Conference Call Participants David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Good day, and thank you for standing by.
PROVO, Utah--(BUSINESS WIRE)--Please replace the release with the following corrected version, which corrects Nine Months Ended September 2026 "Impact of valuation allowance on deferred tax assets" and "Adjusted net income" in the "Reconciliation of Earnings Per Share Excluding Impact of Certain Charges to GAAP Earnings Per Share" table. The updated release reads: NU SKIN ENTERPRISES REPORTS THIRD QUARTER EARNINGS Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue within.
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue within its guidance range. Executive Summary Q3 2026 vs. Prior-year Quarter Revenue $311.0 million; (14.6)% (1.1)% FX impact or $(3.9) million Earnings Per Share (EPS) $(0.02) or $0.10 excluding certain charges compared to $0.34 Customers 609,469; (18)% Paid Affiliates 116,449; (10)% Sales Leaders 26,995; (13)% “Third quarter revenue came in within our guidance range as we continued executin.
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on Dec. 9, 2026, to shareholders of record on Nov. 27, 2026. About Nu Skin Enterprises Inc. Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scient.
Benchmark NUS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Nu Skin Enterprises, Inc. (NUS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $4.10 | $199.06M | -0.85 | -14.26% | -17.72% | -34.83% | 5.74% | |
| $15.28 | $1.58B | 9.21 | 0.89% | 3.37% | — | — | |
| $13.63 | $251.65M | -11.89 | 8.28% | -2.34% | -3.65% | — | |
| $10.87 | $191.15M | 13.26 | 5.67% | 3.05% | 8.76% | — | |
| $12.81 | $142.44M | -3.51 | -35.96% | -13.64% | -21.13% | 0.14% | |
| $110.06 | $39.81B | 109.49 | 5.05% | 2.41% | 9.28% | 1.27% |
Nu Skin Enterprises, Inc. (NUS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Nu Skin Enterprises, Inc. (NUS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 10, 2026·SEC
May 29, 2026·SEC
May 8, 2026·SEC
Get notified when NUS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Nu Skin Enterprises, Inc. (NUS) stock FAQ — growth, dividends, profitability & financials explained
Nu Skin Enterprises, Inc. (NUS) reported $1.32B in revenue over the trailing twelve months. Revenue was $1.49B in fiscal year 2025. That is 119% more than the $678.6M of fiscal year 1996.
Nu Skin Enterprises, Inc. (NUS) revenue fell by 15.3% over the trailing twelve months, compared with the twelve months before.
No. Nu Skin Enterprises, Inc. (NUS) reported a net loss of $234.2M over the trailing twelve months.
Yes. Nu Skin Enterprises, Inc. (NUS) pays a dividend that yields 5.74% at the current price, a high yield.
Nu Skin Enterprises, Inc. (NUS) had a return on equity (ROE) of -34.8% over the trailing twelve months. A negative ROE means the company lost money over the period.
Nu Skin Enterprises, Inc. (NUS) had negative free cash flow of $26.3M over the trailing twelve months.
